Chronic spontaneous urticaria in children: itching for insight.
While there is increasing information about the pathogenesis and treatment of chronic spontaneous urticaria (csU) in adults, there is little published information about csU in children. Consequently, most of the recommendations contained in current guidelines for the prevention and treatment of csU in infants and children is based on extrapolation of data obtained in adults. To rectify this, this review points out critical gaps in our knowledge and suggests strategies which may help us to improve our understanding of this condition. How common is csU in children? What do we know about its clinical presentation and the presence of useful biomarkers? What are its common underlying causes? What is the course of csU in children? How does csU affect the everyday life of children? What treatment options are available for children? To answer these questions, two separate types of information are required. The first is information about the prevalence of the condition in the community at large and how csU affects the everyday life of both the child-patient and the parent or carer. Because most csU cases in infants and children do not come to specialists but are treated by general practitioners or by parents using over-the-counter medications, these questions may be answered only by general population surveys or schools programmes. The second is clinical information including family history and disease presentation, the presence of biomarkers and comorbidities, objective measures of severity, frequency and duration of exacerbations, the response to therapy and the time to remission. Targeted questionnaires need to be developed and validated for these investigations. This has already begun in Germany with the establishment of the CU-KID Netzwerk (Email address: cu-kid@charite.de), the aim of which is to identify clinical centres and colleagues who treat children with urticaria and to initiate the information gathering described above.
Department of Dermatology and Allergy, Charité, Universitätsmedizin Berlin, Charitéplatz 1, Germany. mkc@southampton.ac.uk
Martin K
MK
Church
Karsten
K
Weller
Philippe
P
Stock
Marcus
M
Maurer
D015415:Biomarkers; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D015995:Prevalence; D011537:Pruritus; D011788:Quality of Life; D012720:Severity of Illness Index; D012867:Skin / Q000473:pathology; D014581:Urticaria / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000473:pathology
D015415:Biomarkers; D006634:Histamine H1 Antagonists